المؤلفون: Moura DS; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain. dmoura@atbsarc.org.; Department of Oncology in University Hospital Fundación Jiménez Díaz,, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. dmoura@atbsarc.org., Mondaza-Hernandez JL; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Sanchez-Bustos P; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain., Peña-Chilet M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013, Seville, Spain., Cordero-Varela JA; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain., Lopez-Alvarez M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain., Carrillo-Garcia J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Martin-Ruiz M; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Romero-Gonzalez P; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Renshaw-Calderon M; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Ramos R; Pathology Department, Son Espases University Hospital, 07120, Mallorca, Spain., Marcilla D; Pathology Department, University Hospital Virgen del Rocio, 41013, Seville, Spain., Alvarez-Alegret R; Pathology Department, Miguel Servet University Hospital, 50009, Saragossa, Spain., Agra-Pujol C; Pathology Department, Gregorio Marañon Universitary Hospital, 28007, Madrid, Spain., Izquierdo F; Pathological Anatomy Service, Complejo Asistencial Universitario de León, 24071, Leon, Spain., Ortega-Medina L; Pathology Department, Hospital Clinico San Carlos, 28040, Madrid, Spain., Martin-Davila F; Pathology Department, Ciudad Real General Hospital, 13005, Ciudad Real, Spain., Hernandez-Leon CN; Pathology department, Canarias University Hospital, 38320, Santa Cruz de Tenerife, Spain., Romagosa C; Pathology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Salgado MAV; Medical Oncology Department, Ramon y Cajal University Hospital, 28034, Madrid, Spain., Lavernia J; Medical Oncology Department, Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Bagué S; Pathology Department, Hospital de la Santa Creu i Sant Pau, 08025, Barcelona, Spain., Mayodormo-Aranda E; Pathology Department, Hospital Universitari i Politècnic la Fe, 46026, Valencia, Spain., Alvarez R; Medical Oncology Department, Gregorio Marañon Universitary Hospital, 28007, Madrid, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Martinez-Trufero J; Medical Oncology Department, Miguel Servet University Hospital, 50009, Saragossa, Spain., Castilla-Ramirez C; Pathology Department, University Hospital Virgen del Rocio, 41013, Seville, Spain., Gutierrez A; Hematology Department, Son Espases University Hospital, 07120, Mallorca, Spain., Dopazo J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013, Seville, Spain.; INB-ELIXIR-es, FPS, Hospital Virgen del Rocío, 41013, Seville, Spain., Hindi N; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain., Garcia-Foncillas J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain., Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain. jmartin@atbsarc.org.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain. jmartin@atbsarc.org.; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org.; Department of Oncology in University Hospital Fundación Jiménez Díaz,, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. jmartin@atbsarc.org.

المصدر: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 May 17; Vol. 81 (1), pp. 219. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Trabectedin*/pharmacology , Sarcoma*/drug therapy , Sarcoma*/pathology , Sarcoma*/genetics , Sarcoma*/metabolism , HMGA1a Protein*/metabolism , HMGA1a Protein*/genetics, Humans ; Animals ; Cell Line, Tumor ; Mice ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Drug Resistance, Neoplasm/drug effects ; TOR Serine-Threonine Kinases/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; Signal Transduction/drug effects ; Prognosis ; Female ; Leiomyosarcoma/drug therapy ; Leiomyosarcoma/pathology ; Leiomyosarcoma/genetics ; Leiomyosarcoma/metabolism ; Xenograft Model Antitumor Assays

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.